SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Sigachi Industries - Quaterly Results

25 Jul 2025 Evaluate
The sales moved up 38.48% to Rs. 1109.77 millions for the June 2025 quarter as compared to Rs. 801.38 millions during the year-ago period.The Net Loss for the quarter ended June 2025 is Rs. -991.44 millions as compared to Net Profit of Rs. 92.88 millions of corresponding quarter ended June 2024OP of the company witnessed a marginal growth to 279.02 millions from 180.85 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202506 202406 % Var 202506 202406 % Var 202503 202403 % Var
Sales 1109.77 801.38 38.48 1109.77 801.38 38.48 4078.33 3175.00 28.45
Other Income 39.41 16.77 135.00 39.41 16.77 135.00 200.77 115.73 73.48
PBIDT 279.02 180.85 54.28 279.02 180.85 54.28 943.39 708.66 33.12
Interest 21.47 28.84 -25.55 21.47 28.84 -25.55 106.57 70.20 51.81
PBDT -952.51 152.01 -726.61 -952.51 152.01 -726.61 836.82 638.46 31.07
Depreciation 39.50 24.78 59.40 39.50 24.78 59.40 129.22 87.09 48.38
PBT -992.01 127.23 -879.70 -992.01 127.23 -879.70 707.60 551.37 28.33
TAX -0.57 34.35 -101.66 -0.57 34.35 -101.66 230.92 141.23 63.51
Deferred Tax -0.57 7.63 -107.47 -0.57 7.63 -107.47 105.18 32.08 227.87
PAT -991.44 92.88 -1167.44 -991.44 92.88 -1167.44 476.68 410.14 16.22
Equity 382.12 328.20 16.43 382.12 328.20 16.43 382.12 328.20 16.43
PBIDTM(%) 25.14 22.57 11.41 25.14 22.57 11.41 23.13 22.32 3.64

Sigachi Industries Share Price

23.35 0.04 (0.17%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×